Because CDER and CBER are responsible for the regulation of different types of products, each Center plans to establish a Change Control Board (CCB) that will be responsible for analyzing feedback and input on the benefit-risk framework from their respective review staffs and making recommendations for enhancements to the framework and the clinical review templates for each Center.